Alterations in DNA Methylation in Peripheral Blood May Indicate Lymphoma Development in Primary Sjögren's Disease
By
Hanna Lidberg
Cecilia Fugmann
Juliana Imgenberg-Kreuz
July 9, 2026
Clinical Scorecard: Alterations in DNA Methylation in Peripheral Blood May Indicate Lymphoma Development in Primary Sjögren's Disease
At a Glance
Category Detail
Condition Primary Sjögren's Disease Key Mechanisms DNA methylation changes associated with lymphoma development Target Population Patients with Primary Sjögren's Disease Care Setting Rheumatology and autoimmune disease management
Key Highlights
DNA methylation patterns in blood may indicate lymphoma risk in SjD. Significant differential methylation observed in 473 CpG positions. 87% of identified DMPs were hypomethylated in patients pre-lymphoma. Functional enrichment linked to immune activation and leukocyte signaling. Altered immune cell proportions noted in patients sampled pre-lymphoma. Guideline-Based Recommendations
Diagnosis
Monitor DNA methylation patterns in patients with Primary Sjögren's Disease. Management
Integrate epigenetic markers with clinical assessments for risk stratification. Monitoring & Follow-up
Regularly assess immune cell proportions and methylation changes. Risks
Increased risk of lymphoma in patients with altered DNA methylation. Patient & Prescribing Data
Patients diagnosed with Primary Sjögren's Disease.
Focus on early identification of high-risk patients through biomarker analysis.
Clinical Best Practices
Utilize epigenetic profiling for early detection of lymphoma risk. Incorporate immune cell analysis in routine evaluations of SjD patients. Related Resources & Content
